Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 19
Original Research
Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in Italy
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,584 | Dovepress* | 3,232+ | 114 | 3,346 | |
| PubMed Central* | 352 | 151 | 503 | ||
| Totals | 3,584 | 265 | 3,849 | ||
| *Since 28 March 2023 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar